Progress in Antifungal Susceptibility Testing of Candida spp. by Use of Clinical and Laboratory Standards Institute Broth Microdilution Methods, 2010 to 2012

Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America

Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191

Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance

Ghannoum, M. A., & Rice, L. B. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.4.501 · Cited by 1,811

Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis

Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380

Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance

White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353

Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality

Morrell, M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3640-3645.2005 · Cited by 1,286

Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: A multi-institutional study.

Garey, K. W., Rege, M., Pai, M. P., Mingo, D. E., Suda, K. J., Turpin, R. S., & Bearden, D. T. (2006) · Clinical Infectious Diseases · doi:10.1086/504810 · Cited by 1,171

A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia

Rex, J. H., Bennett, J. E., Sugar, A. M., Pappas, P. G., van der Horst, C. M., Edwards, J. E., Washburn, R. G., Scheld, W. M., Karchmer, A. W., Dine, A. P., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411173312001 · Cited by 1,039

Candida and candidiasis.

Calderone, R. (2012) · ASM Press eBooks · Cited by 912

Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment

Pfaller, M. A. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.11.001 · Cited by 903

Epidemiology of Invasive Mycoses in North America

Pfaller, M. A., & Diekema, D. J. (2010) · Critical Reviews in Microbiology · doi:10.3109/10408410903241444 · Cited by 901

Candida glabrata – unique features and challenges in the clinical management of invasive infections

Glöckner, A., & Cornely, O. A. (2015) · Mycoses · doi:10.1111/myc.12348 · Cited by 49

Determinants of fluconazole resistance and echinocandin tolerance in C. parapsilosis isolates causing a large clonal candidemia outbreak among COVID-19 patients in a Brazilian ICU

Daneshnia, F., de Almeida, J. N., Arastehfar, A. A., Lombardi, L., Shor, E., Moreno, L., Mendes, A. V. A., Barberino, M. G., Thomaz, D. Y., Butler, G., et al. (2022) · Emerging Microbes & Infections · doi:10.1080/22221751.2022.2117093 · Cited by 47

The role of drug efflux pumps in Malassezia pachydermatis and Malassezia furfur defence against azoles

Iatta, R., Puttilli, M. R., Immediato, D., Otranto, D., & Cafarchia, C. (2016) · Mycoses · doi:10.1111/myc.12577 · Cited by 47

Molecular Identification, Genotypic Diversity, Antifungal Susceptibility, and Clinical Outcomes of Infections Caused by Clinically Underrated Yeasts, Candida orthopsilosis, and Candida metapsilosis: An Iranian Multicenter Study (2014–2019)

Arastehfar, A. A., Khodavaisy, S., Daneshnia, F., Najafzadeh, M. J., Mahmoudi, S., Charsizadeh, A., Salehi, M., Zarrinfar, H., Raeisabadi, A., Dolatabadi, S., et al. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00264 · Cited by 49

Isavuconazole and Nine Comparator Antifungal Susceptibility Profiles for Common and Uncommon Candida Species Collected in 2012: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values

Castanheira, M., Messer, S. A., Rhomberg, P. R., Dietrich, R. D., Jones, R. N., & Pfaller, M. A. (2014) · Mycopathologia · doi:10.1007/s11046-014-9772-2 · Cited by 46

Identification and Antifungal Susceptibility Profiles of Candida nivariensis and Candida bracarensis in a Multi-Center Chinese Collection of Yeasts

Hou, X., Xiao, M., Chen, S. C.-A., Wang, H., Yu, S.-Y., Fan, X., Kong, F., & Xu, Y. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00005 · Cited by 46

Prevalence and Antifungal Susceptibility of Pathogenic Yeasts in China: A 10-Year Retrospective Study in a Teaching Hospital

Song, Y., Chen, X., Yan, Y., Wan, Z., Liu, W. Y., & Li, R. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01401 · Cited by 46

A rare case of breakthrough fungal pericarditis due to fluconazole-resistant Candida auris in a patient with chronic liver disease

Khillan, V., Rathore, N., Kathuria, S., & Chowdhary, A. (2014) · JMM Case Reports · doi:10.1099/jmmcr.0.t00018 · Cited by 47

Quantitation of ergosterol content and gene expression profile of ERG11 gene in fluconazole-resistant Candida albicans

Alizadeh, F., Khodavandi, A., & Zalakian, S. (2017) · Current Medical Mycology · doi:10.29252/cmm.3.1.13 · Cited by 45

Effect of fluconazole prophylaxis on Candida fluconazole susceptibility in premature infants

Autmizguine, J., Smith, P. B., Prather, K. O., Bendel, C. M., Natarajan, G., Bidegain, M., Kaufman, D. A., Burchfield, D. J., Ross, A., Pandit, P., et al. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky353 · Cited by 45

First multicentre report of in vitro resistance rates in candidaemia isolates in Turkey

Arıkan-Akdağlı, S., Gülmez, D., Doğan, Ö., Çerikçioğlu, N., Dereli, M. D., Bırıncı, A., Yıldıran, Ş. T., Ener, B., Öz, Y., Metin, D. Y., et al. (2019) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2019.04.003 · Cited by 45

Species distribution and susceptibility profiles of Candida species isolated from vulvovaginal candidiasis, emergence of C. lusitaniae

Hashemi, S. E., Shokohi, T., Abastabar, M., Aslani, N., Ghadamzadeh, M., & Haghani, I. (2019) · Current Medical Mycology · doi:10.18502/cmm.5.4.2062 · Cited by 45

Echinocandin Resistance in Candida Species Isolates from Liver Transplant Recipients

Prigent, G., Aït‐Ammar, N., Levesque, É., Fekkar, A., Costa, J., Anbassi, S. E., Foulet, F., Duvoux, C., Merle, J., Dannaoui, É., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01229-16 · Cited by 44

Emerging Candida species isolated from renal transplant recipients: Species distribution and susceptibility profiles

Diba, K., Makhdoomi, K., Nasri, E., Vaezi, A., Javidnia, J., Gharabag, D. J., Jazani, N. H., Chavshin, A. R., Badiee, P., Badali, H., et al. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.09.026 · Cited by 43

SUSCEPTIBILITY OF Candida spp. ISOLATED FROM BLOOD CULTURES AS EVALUATED USING THE M27-A3 AND NEW M27-S4 APPROVED BREAKPOINTS

dos Santos, E. R., Forno, C. F. D., Liscano, M. G. H., Kubiça, T. F., Venturini, T. P., Chassot, F., Santurio, J. M., & Alves, S. H. (2014) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s0036-46652014000600004 · Cited by 42

Low level of antifungal resistance of Candida glabrata blood isolates in Turkey: Fluconazole minimum inhibitory concentration and FKS mutations can predict therapeutic failure

Arastehfar, A. A., Daneshnia, F., Salehi, M., Yaşar, M., Hoşbul, T., İlkit, M., Pan, W., Hagen, F., Arslan, N. P., Dağı, H. T., et al. (2020) · Mycoses · doi:10.1111/myc.13104 · Cited by 42

Genetic Basis of Azole and Echinocandin Resistance in Clinical Candida glabrata in Japan

Khalifa, H. O., Arai, T., Majima, H., Watanabe, A., & Kamei, K. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00783-20 · Cited by 42

A High Rate of Recurrent Vulvovaginal Candidiasis and Therapeutic Failure of Azole Derivatives Among Iranian Women

Arastehfar, A. A., Kargar, M. L., Mohammadi, S. R., Roudbary, M., Ghods, N., Haghighi, L., Daneshnia, F., Tavakoli, M., Jafarzadeh, J., Hedayati, M. T., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.655069 · Cited by 45

In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012

Pfaller, M. A., Castanheira, M., Messer, S. A., & Jones, R. N. (2015) · Mycoses · doi:10.1111/myc.12299 · Cited by 41

Filamentous Fungi

Powers‐Fletcher, M. V., Kendall, B. A., Griffin, A. T., & Hanson, K. E. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.dmih2-0002-2015 · Cited by 41

Recent Increase in the Prevalence of Fluconazole-Non-susceptible Candida tropicalis Blood Isolates in Turkey: Clinical Implication of Azole-Non-susceptible and Fluconazole Tolerant Phenotypes and Genotyping

Arastehfar, A., Hilmioğlu-Polat, S., Daneshnia, F., Hafez, A., Salehi, M., Polat, F., Yaşar, M., Arslan, N., Hoşbul, T., Ünal, N., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.587278 · Cited by 40

Distribution, virulence attributes and antifungal susceptibility patterns ofCandida parapsilosiscomplex strains isolated from clinical samples

Tosun, İ., Akyuz, Z., Güler, N. C., Gülmez, D., Bayramoğlu, G., Kaklıkkaya, N., Arıkan-Akdağlı, S., & Aydın, F. (2012) · Medical Mycology · doi:10.3109/13693786.2012.745953 · Cited by 39

Candidemia due to uncommon Candida species in children: new threat and impacts on outcomes

Tsai, M.-H., Hsu, J., Yang, L., Pan, Y., Lai, M., Chu, S., Huang, H., Chiang, M., Fu, R.-H., & Lu, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-33662-x · Cited by 39

An investigation of Candida species isolated from blood cultures during 17 years in a university hospital

Kazak, E., Akın, H., Ener, B., Sığırlı, D., Özkan, Ö., Gürcüoğlu, E., Yılmaz, E., Çelebi, S., Akçağlar, S., & Akalın, H. (2014) · Mycoses · doi:10.1111/myc.12209 · Cited by 39

ANTIFUNGAL SUSCEPTIBILITY TESTING: CURRENT ROLE FROM THE CLINICAL LABORATORY PERSPECTIVE

Posteraro, B., Torelli, R., Carolis, E. D., Posteraro, P., & Sanguinetti, M. (2014) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2014.030 · Cited by 38

Clinical and epidemiological characteristics and risk factors for mortality in patients with candidemia in hospitals from Bogotá, Colombia

Cortés, J. A., Reyes, P., Gómez, C., Cuervo, S. I., Rivas, P., Casas, C. A., & Sánchez, R. (2014) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2014.06.009 · Cited by 38

Micafungin breakthrough fungemia in patients with hematological disorders

Kimura, M., Araoka, H., Yamamoto, H., Nakamura, S., Nagi, M., Yamagoe, S., Miyazaki, Y., Ogura, S., Mitsuki, T., Yuasa, M., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02183-17 · Cited by 37

Surveillance of antifungal susceptibilities in clinical isolates of Candida species at 36 hospitals in China from 2009 to 2013

Zhang, L., Zhou, S., Pan, A., Li, J., & Liu, B. (2014) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2014.12.033 · Cited by 37

Comparison of the Vitek 2 yeast susceptibility system with CLSI microdilution for antifungal susceptibility testing of fluconazole and voriconazole against Candida spp., using new clinical breakpoints and epidemiological cutoff values

Pfaller, M. A., Diekema, D. J., Procop, G. W., & Rinaldi, M. G. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.05.019 · Cited by 37

Strong synergism of dexamethasone in combination with fluconazole against resistant Candida albicans mediated by inhibiting drug efflux and reducing virulence

Sun, W., Wang, D., Yu, C., Huang, X., Li, X., & Sun, S. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.03.015 · Cited by 37

Synthesis and antifungal activity of novel oxazolidin-2-one-linked 1,2,3-triazole derivatives

Ramírez-Villalva, A., González‐Calderón, D., Rojas-García, R. I., González‐Romero, C., Tamaríz-Mascarúa, J., Morales-Rodríguez, M., Zavala‐Segovia, N., & Fuentes‐Benítes, A. (2017) · MedChemComm · doi:10.1039/c7md00442g · Cited by 37

Reduced Antifungal Susceptibility of Vulvovaginal Candida Species at Normal Vaginal pH Levels: Clinical Implications

Spitzer, M., & Wiederhold, N. P. (2018) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000383 · Cited by 37

Fluconazole impacts the extracellular matrix of fluconazole-susceptible and -resistant Candida albicans and Candida glabrata biofilms

Panariello, B. H. D., Klein, M. I., Mima, E. G. D. O., & Pavarina, A. C. (2018) · Journal of Oral Microbiology · doi:10.1080/20002297.2018.1476644 · Cited by 37

Surveillance of Candida spp Bloodstream Infections: Epidemiological Trends and Risk Factors of Death in Two Mexican Tertiary Care Hospitals

Corzo-León, D., Matute, T. A., Colombo, A. L., Cornejo‐Juárez, P., Cortés, J. A., Echevarria, J. I., Guzmán-Blanco, M., Macías, A. E., Nucci, M., Ostrosky-Zeichner, L. L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097325 · Cited by 38

Antifungal Susceptibilities of Bloodstream Isolates of Candida Species from Nine Hospitals in Korea: Application of New Antifungal Breakpoints and Relationship to Antifungal Usage

Won, E. J., Shin, J. H., Choi, M. J., Lee, W. G., Park, Y.-J., Uh, Y., Kim, S.-Y., Lee, M., Kim, S. H., Shin, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118770 · Cited by 36

Multicentre study to determine the Etest epidemiological cut-off values of antifungal drugs in Candida spp. and Aspergillus fumigatus species complex

Salsé, M., Gangneux, J., Cassaing, S., Delhaès, L., Fekkar, A., Dupont, D., Botterel, F., Costa, D., Bourgeois, N., Bouteille, B., et al. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.04.027 · Cited by 36

Alginate/pectin dressing with niosomal mangosteen extract for enhanced wound healing: evaluating skin irritation by structure-activity relationship

Pooprommin, P., Manaspon, C., Dwivedi, A., Mazumder, A., Sangkaew, S., Wanmasae, S., Tangpong, J., Ongtanasup, T., & Eawsakul, K. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e12032 · Cited by 35

Surveillance of the prevalence, antibiotic susceptibility, and genotypic characterization of invasive candidiasis in a teaching hospital in China between 2006 to 2011

Li, F., Wu, L., Cao, B., Zhang, Y., Li, X., & Liu, Y. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-353 · Cited by 35

Ibuprofen Potentiates the In Vivo Antifungal Activity of Fluconazole against Candida albicans Murine Infection

Costa‐de‐Oliveira, S., Miranda, I. M., Silva-Dias, A., Silva, A. P., Rodrigues, A. G., & Pina‐Vaz, C. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05056-14 · Cited by 35

Influence of cancer treatment on the Candida albicans isolated from the oral cavities of cancer patients

Ramla, S., Sharma, V., & Patel, M. (2015) · Supportive Care in Cancer · doi:10.1007/s00520-015-3035-8 · Cited by 35

Meyerozyma guilliermondii species complex: review of current epidemiology, antifungal resistance, and mechanisms

Ghasemi, R., Lotfali, E., Rezaei, K., Madinehzad, S. A., Tafti, M. F., Aliabadi, N., Kouhsari, E., & Fattahi, A. (2022) · Brazilian Journal of Microbiology · doi:10.1007/s42770-022-00813-2 · Cited by 35

Candida parapsilosis Mdr1B and Cdr1B Are Drivers of Mrr1-Mediated Clinical Fluconazole Resistance

Doorley, L. A., Rybak, J. M., Berkow, E. L., Zhang, Q. H., Morschhäuser, J., & Rogers, P. D. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00289-22 · Cited by 34

Species distribution and antifungal susceptibility profile of Candida isolates from bloodstream infections in Lima, Peru

Bustamante, B., Martins, M. A., Bonfietti, L. X., Szeszs, M. W., Jacobs, J. A., García, C., & Melhem, M. D. S. C. (2014) · Journal of Medical Microbiology · doi:10.1099/jmm.0.071167-0 · Cited by 34

Molecular Identification of Candida Species Isolated from Onychomycosis in Shanghai, China

Feng, X., Ling, B., Yang, X., Liao, W., Pan, W., & Yao, Z. (2015) · Mycopathologia · doi:10.1007/s11046-015-9927-9 · Cited by 34

Breakthrough Solution for Antimicrobial Resistance Detection: Surface‐Enhanced Raman Spectroscopy‐based on Artificial Intelligence

Al‐Shaebi, Z., Akdeniz, M., Ahmed, A. O., Altunbek, M., & Aydin, Ö. F. (2023) · Advanced Materials Interfaces · doi:10.1002/admi.202300664 · Cited by 33

Physiological Differences in Cryptococcus neoformans Strains In Vitro versus In Vivo and Their Effects on Antifungal Susceptibility

Grossman, N. T., & Casadevall, A. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02108-16 · Cited by 35

Risk factors, characteristics, and outcomes of candidemia in an adult intensive care unit in Turkey

Tigen, E. T., Bilgin, H., Gürün, H. P., Doğru, A., Özben, B., Çerikçioğlu, N., & Korten, V. (2017) · American Journal of Infection Control · doi:10.1016/j.ajic.2017.02.022 · Cited by 33

Epidemiology of candidemia in Shiraz, southern Iran: A prospective multicenter study (2016–2018)

Arastehfar, A. A., Yazdanpanah, S., Bakhtiari, M., Fang, W., Pan, W., Mahmoudi, S., Pakshir, K., Daneshnia, F., Boekhout, T., İlkit, M., et al. (2020) · Medical Mycology · doi:10.1093/mmy/myaa059 · Cited by 33

Candidemia Among Coronavirus Disease 2019 Patients in Turkey Admitted to Intensive Care Units: A Retrospective Multicenter Study

Arastehfar, A. A., Ünal, N., Hoşbul, T., Özarslan, M. A., Karakoyun, A. S., Polat, F., Fuentes, D., Gümral, R., Turunç, T., Daneshnia, F., et al. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac078 · Cited by 33

Effect of initial antifungal therapy on mortality among patients with bloodstream infections with different Candida species and resistance to antifungal agents: A multicentre observational study by the Turkish Fungal Infections Study Group

Doğan, Ö., Yesilkaya, A., Menekşe, Ş., Güler, Ö., Karakoç, Ç., Çınar, G., Kapmaz, M., Aydın, M., Keske, Ş., Şahin, S., et al. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105992 · Cited by 32

Conventional therapy and new antifungal drugs againstMalasseziainfections

Rhimi, W., Theelen, B., Boekhout, T., Aneke, C. I., Otranto, D., & Cafarchia, C. (2020) · Medical Mycology · doi:10.1093/mmy/myaa087 · Cited by 32

Brevibacillus laterosporus isolated from the digestive tract of honeybees has high antimicrobial activity and promotes growth and productivity of honeybee’s colonies

Khaled, J. M. A., Al‐Mekhlafi, F. A., Mothana, R. A., Alharbi, N. S. H. A., Alzahrani, K. E., Sharafaddin, A. H., Kadaikunnan, S., Alobaidi, A. S., Bayaqoob, N. I., Govindarajan, M., et al. (2017) · Environmental Science and Pollution Research · doi:10.1007/s11356-017-0071-6 · Cited by 32

Antifungal Susceptibilities of Candida Isolates Causing Bloodstream Infections at a Medical Center in Taiwan, 2009-2010

Huang, Y., Liu, C., Liao, C., Chung, K., Sheng, W., & Hsueh, P. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01035-13 · Cited by 31

Clinical features of patients with infections caused by Candida guilliermondii and Candida fermentati and antifungal susceptibility of the isolates at a medical centre in Taiwan, 2001-10

Chen, Y., Huang, S., Tang, J., Tsay, W., Yao, M., Ko, B., Chou, W., Tien, H., & Hsueh, P. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt214 · Cited by 31

The synergistic antifungal effects of sodium phenylbutyrate combined with azoles against Candida albicans via the regulation of the Ras–cAMP–PKA signalling pathway and virulence

Sun, W., Zhang, L., Lu, X., Feng, L., & Sun, S. (2018) · Canadian Journal of Microbiology · doi:10.1139/cjm-2018-0337 · Cited by 32

ERG11 Gene Mutations and MDR1 Upregulation Confer Pan-Azole Resistance in Candida tropicalis Causing Disseminated Candidiasis in an Acute Lymphoblastic Leukemia Patient on Posaconazole Prophylaxis

You, L., Qian, W., Yang, Q., Mao, L., Zhu, L., Huang, X., Jin, J., & Meng, H. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02496-16 · Cited by 31

Candidemia in Brazilian neonatal intensive care units: risk factors, epidemiology, and antifungal resistance

da Silva, C. M., de Carvalho, A. M. R., Macêdo, D. P. C., Jucá, M. B., Amorim, R. D. J. M., & Neves, R. P. (2023) · Brazilian Journal of Microbiology · doi:10.1007/s42770-023-00943-1 · Cited by 32

The future of fungal susceptibility testing

Posteraro, B., & Sanguinetti, M. (2014) · Future Microbiology · doi:10.2217/fmb.14.55 · Cited by 32

Update from the Laboratory

Bataineh, M. T. A., Sutton, D. A., Fothergill, A. W., & Wiederhold, N. P. (2015) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2015.10.014 · Cited by 30

Candida profiles and antifungal resistance evolution over a decade in Lebanon

Araj, G. F., Asmar, R. G., & Avedissian, A. Z. (2015) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.6550 · Cited by 30

Clinical and Microbiological Characteristics of Breakthrough Candidemia in Allogeneic Hematopoietic Stem Cell Transplant Recipients in a Japanese Hospital

Kimura, M., Araoka, H., Yamamoto, H., Asano‐Mori, Y., Nakamura, S., Yamagoe, S., Ohno, H., Miyazaki, Y., Abe, M., Yuasa, M., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01791-16 · Cited by 30

In Vitro Activities of Novel Azole Compounds ATTAF-1 and ATTAF-2 against Fluconazole-Susceptible and -Resistant Isolates of Candida Species

Fakhim, H., Emami, S., Vaezi, A., Hashemi, S. M., Faeli, L., Diba, K., Dannaoui, É., & Badali, H. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01106-16 · Cited by 29

Inhibitory Activity of Essential Oils against Vibrio campbellii and Vibrio parahaemolyticus

Zheng, X., Feyaerts, A. F., Dijck, P. V., & Bossier, P. (2020) · Microorganisms · doi:10.3390/microorganisms8121946 · Cited by 29

Dynamics and Predictors of Mortality Due to Candidemia Caused by Different Candida Species: Comparison of Intensive Care Unit-Associated Candidemia (ICUAC) and Non-ICUAC

Kwon, Y. J., Won, E. J., Jeong, S. H., Shin, K. S., Shin, J. H., Kim, Y. R., Kim, Y. R., Kim, H. S., Kim, Y. A., Kim, T. S., et al. (2021) · Journal of Fungi · doi:10.3390/jof7080597 · Cited by 32

Oxidative imbalance in Candida tropicalis biofilms and its relation with persister cells

da Silva, M. A., Baronetti, J. L., Páez, P. L., & Paraje, M. G. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.598834 · Cited by 28

In Vitro and In Vivo Interactions of TOR Inhibitor AZD8055 and Azoles against Pathogenic Fungi

Sun, Y., Tan, L., Yao, Z., Gao, L., Yang, J. Y., & Zeng, T. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02007-21 · Cited by 29

Micafungin: an evidence-based review of its place in therapy

Reboli, A. C., & de la Torre (2014) · Core evidence · doi:10.2147/ce.s36304 · Cited by 28

Anti-Biofilm Activity of Chlorogenic Acid against Pseudomonas Using Quorum Sensing System

Wang, L., Cao, X., Pei, H., Liu, P., Song, Y., & Wu, Y. (2023) · Foods · doi:10.3390/foods12193601 · Cited by 28

Successful treatment with caspofungin of candiduria in a child with Wilms tumor; review of literature

Rezai, M. S., Vaezi, A., Fakhim, H., Soleimani, A., Jafari, H. M., Mohseni, S., & Badali, H. (2017) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2017.01.006 · Cited by 27

Insecticidal and fungicidal performance of bio-fabricated silver and gold nanoparticles

Mondal, A., Chowdhury, S., Mondal, N. K., Shaikh, W. A., Debnath, P., & Chakraborty, S. (2021) · International Journal of Environmental Science and Technology · doi:10.1007/s13762-021-03181-w · Cited by 27

Antifungal susceptibility profile of Candida clinical isolates from 22 hospitals of São Paulo State, Brazil

Rodrigues, D. K. D. B., Bonfietti, L. X., Garcia, R. A., Araújo, M. R., Rodrigues, J. S., Gimenes, V. M. F., & Melhem, M. D. S. C. (2021) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x2020e10928 · Cited by 27

Investigation of the Emerging Nosocomial Wickerhamomyces anomalus Infections at a Chinese Tertiary Teaching Hospital and a Systemic Review: Clinical Manifestations, Risk Factors, Treatment, Outcomes, and Anti-fungal Susceptibility

Zhang, L., Xiao, M., Arastehfar, A. A., İlkit, M., Zou, J., Deng, Y., Xu, Y., Liao, W., Zhao, J., Fang, W., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.744502 · Cited by 27

Epidemiology of candidemia in NICE area, France: A five-year study of antifungal susceptibility and mortality

Vannini, M., Emery, S., Lieutier-Colas, F., Legueult, K., Mondain, V., Retur, N., Gastaud, L., Pomares-Estran, C., & Hasseine, L. (2021) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2021.101210 · Cited by 27

The Widely Used ATB FUNGUS 3 Automated Readings in China and Its Misleading High MICs of Candida spp. to Azoles: Challenges for Developing Countries' Clinical Microbiology Labs

Zhang, L., Wang, H., Xiao, M., Kudinha, T., Mao, L.-L., Zhao, H.-R., Kong, F., & Xu, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114004 · Cited by 27

Antifungal susceptibility and molecular typing of 115Candida albicansisolates obtained from vulvovaginal candidiasis patients in 3 Shanghai maternity hospitals

Ying, C., Zhang, H., Tang, Z., Chen, H., Gao, J. Q., & Yue, C. (2015) · Medical Mycology · doi:10.1093/mmy/myv082 · Cited by 27

Clinical features, antifungal susceptibility, and outcome of Candida guilliermondii fungemia: An experience in a tertiary hospital in mid-Taiwan

Tseng, T.-Y., Chen, T., Ho, C., Lin, P., Chou, C.-H., Tsai, C.-T., Wang, J.-H., Chi, C.-Y., & Ho, M. (2017) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2016.08.015 · Cited by 27

Clinical manifestations of candidemia caused by uncommon Candida species and antifungal susceptibility of the isolates in a regional hospital in Taiwan, 2007–2014

Liu, W., Lai, C., Li, M.-C., Wu, C.-J., Ko, W., Hung, Y.-L., Tang, H.-J., & Hsueh, P. (2017) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2017.08.007 · Cited by 27

Epidemiology and Antifungal Susceptibilities of Yeast Isolates Causing Invasive Infections Across Urban Beijing, China

Guo, L., Xiao, M., Cao, B., Qu, F., Zhan, Y., Hu, Y., Wang, X., Liang, G., Gu, H., Qi, J., et al. (2017) · Future Microbiology · doi:10.2217/fmb-2017-0036 · Cited by 28

First description of Candida nivariensis in Brazil: Antifungal susceptibility profile and potential virulence attributes

Figueiredo-Carvalho, M. H. G., Ramos, L. D. S., Barbedo, L. S., Chaves, A. L. D. S., Muramoto, I. A., Santos, A. L. S. D., Almeida-Paes, R., & Zancopé-Oliveira, R. M. (2016) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760150376 · Cited by 26

A simple prediction score for estimating the risk of candidaemia caused by fluconazole non-susceptible strains

Cuervo, G., Puig‐Asensio, M., García‐Vidal, C., Fernández‐Ruiz, M., Pemán, J., Nucci, M., Aguado, J. M., Salavert, M., González‐Romo, F., Guinea, J., et al. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.02.029 · Cited by 26

Propensity Score Analysis of the Role of Initial Antifungal Therapy in the Outcome of Candida glabrata Bloodstream Infections

Puig‐Asensio, M., Fernández‐Ruiz, M., Aguado, J. M., Merino, P., Lora, D., Guinea, J., Martín‐Dávila, P., Cuenca‐Estrella, M., & Almirante, B. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00195-16 · Cited by 26

A Mini Review of Candida Species in Hospital Infection: Epidemiology,Virulence Factor and Drugs Resistance and Prophylaxis

Pitangui, N. D. S. (2013) · Tropical Medicine & Surgery · doi:10.4172/2329-9088.1000141 · Cited by 26

Efficacy of a Fixed Combination of Tetracycline, Chloramphenicol, and Colistimethate Sodium for Treatment of Candida albicans Keratitis

Blanco, A. R., Nostro, A., D’Angelo, V., D’Arrigo, M., Mazzone, M. G., & Marino, A. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-22047 · Cited by 26

Changing Epidemiology of Invasive Candidiasis in Children during a 10-Year Period

Noni, M., Stathi, A., Vaki, I., Velegraki, A., Zachariadou, L., & Michos, A. G. (2019) · Journal of Fungi · doi:10.3390/jof5010019 · Cited by 26

Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment

Woodburn, K. W., Clemens, L. E., Jaynes, J., Joubert, L.-M., Botha, A., Nazik, H., & Stevens, D. A. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02690-18 · Cited by 25

Oral Prevalence of Candida Species in Patients Undergoing Systemic Glucocorticoid Therapy and the Antifungal Sensitivity of the Isolates

Xiao, J., Xu, G., de Hoog, S., Qiao, J., Fang, H., & Li, Y. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s262311 · Cited by 25

Support for the EUCAST and revised CLSI fluconazole clinical breakpoints by Sensititre(R) YeastOne(R) for Candida albicans: a prospective observational cohort study

van Hal, S. J., Chen, S. C. A., Sorrell, T. C., Ellis, D. H., Slavin, M. A., & Marriott, D. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku124 · Cited by 25

Trends in Pediatric Candidemia: Epidemiology, Anti-Fungal Susceptibility, and Patient Characteristics in a Children’s Hospital

Piqueras, A., Ganapathi, L., Carpenter, J. F., Rubio, T. T., Sandora, T. J., Flett, K. B., & Köhler, J. R. (2021) · Journal of Fungi · doi:10.3390/jof7020078 · Cited by 25

The distribution and drug susceptibilities of clinical Candida species in TSARY 2014

Zhou, Z.-L., Lin, C.-C., Chu, W.-L., Yang, Y.-L., & Lo, H. (2016) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2016.09.009 · Cited by 24

Molecular Characterization of Candida parapsilosis by Microsatellite Typing and Emergence of Clonal Antifungal Drug Resistant Strains in a Multicenter Surveillance in China

Zhang, L., Yu, S.-Y., Chen, S. C.-A., Xiao, M., Kong, F., Wang, H., Ning, Y., Lu, M., Sun, T., Hou, X., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01320 · Cited by 24

Mechanistic evaluations of ketoconazole lipidic nanoparticles for improved efficacy, enhanced topical penetration, cellular uptake (L929 and J774A.1), and safety assessment: In vitro and in vivo studies

Ramzan, M., Kaur, G., Trehan, S., Agrewala, J. N., Michniak‐Kohn, B. B., Hussain, A., Mahdi, W. A., Gulati, J. S., & Kaur, I. P. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102743 · Cited by 24

In vitro activity of two amphotericin B formulations against Malassezia furfur strains recovered from patients with bloodstream infections

Iatta, R., Immediato, D., Montagna, M. T., Otranto, D., & Cafarchia, C. (2015) · Medical Mycology · doi:10.1093/mmy/myu089 · Cited by 24

Epidemiology, practice patterns, and prognostic factors for candidemia; and characteristics of fourteen patients with breakthrough Candida bloodstream infections: a single tertiary hospital experience in Japan

Hirano, R., Sakamoto, Y., Kitazawa, J., Yamamoto, S., & Kayaba, H. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s156633 · Cited by 24

Resistance reversal induced by a combination of fluconazole and tacrolimus (FK506) in Candida glabrata

Li, H., Chen, Z., Zhang, W., Gao, Y., Zhang, X., & Sun, S. (2014) · Journal of Medical Microbiology · doi:10.1099/jmm.0.081760-0 · Cited by 25

Whole-genome sequencing confirms a persistent candidaemia clonal outbreak due to multidrug-resistant Candida parapsilosis

Daneshnia, F., Polat, S. H., İlkit, M., Fuentes, D., Lombardi, L., Binder, U., Scheler, J., Hagen, F., Mansour, M. K., Butler, G., et al. (2023) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkad112 · Cited by 23

Candida parapsilosis isolates carrying mutations outside FKS1 hotspot regions confer high echinocandin tolerance and facilitate the development of echinocandin resistance

Daneshnia, F., Arastehfar, A. A., Lombardi, L., Binder, U., Scheler, J., Vahedi‐Shahandashti, R., Hagen, F., Lass‐Flörl, C., Mansour, M. K., Butler, G., et al. (2023) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2023.106831 · Cited by 23

Novel Flavonoid Glycosides of Quercetin from Leaves and Flowers of Gaiadendron punctatum G.Don. (Violeta de Campo), used by the Saraguro Community in Southern Ecuador, Inhibit α-Glucosidase Enzyme

Cedeño, H., Espinosa, S., Andrade, J. M., Cartuche, L., & Malagón, O. (2019) · Molecules · doi:10.3390/molecules24234267 · Cited by 23

Comparison of the Sensititre YeastOne antifungal method with the CLSI M27-A3 reference method to determine the activity of antifungal agents against clinical isolates of Candidaspp.

Altınbaş, R., Barış, A., Şen, S., Öztürk, R., & Kiraz, N. (2020) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1909-97 · Cited by 22

Prevalence of Antifungal Resistance, Genetic Basis of Acquired Azole and Echinocandin Resistance, and Genotyping of Candida krusei Recovered from an International Collection

Khalifa, H. O., Hubka, V., Watanabe, A., Nagi, M., Miyazaki, Y., Yaguchi, T., & Kamei, K. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01856-21 · Cited by 22

Investigation of antimicrobial resistance patterns and molecular typing of Pseudomonas aeruginosa isolates among Coronavirus disease-19 patients

Shiralizadeh, S., Keramat, F., Hashemi, S. H., Majzoobi, M. M., Azimzadeh, M., Alikhani, M. S., Karami, P., Rahimi, Z., & Alikhani, M. Y. (2023) · BMC Microbiology · doi:10.1186/s12866-023-02825-w · Cited by 22

Advances in Antifungal Susceptibility Testing of Candida, 2010–2012

Pfaller, M. A., Castanheira, M., & Jones, R. N. (2012) · Current Fungal Infection Reports · doi:10.1007/s12281-012-0092-z · Cited by 3

New developments in the antifungal susceptibility testing of Candida

Pfaller, M. A. (2008) · Current Fungal Infection Reports · doi:10.1007/s12281-008-0019-x · Cited by 9

In vitro Antifungal Susceptibility Profiles of Echinocandins and Triazoles for Clinical Opportunistic Candida isolates by E-test method

Singh, S. (2018) · International Journal for Research in Applied Science and Engineering Technology · doi:10.22214/ijraset.2018.4551

Antifungal susceptibility testing of Candida in the Clinical Laboratory: how to do it, when to do it, and how to interpret it

Manso, E., Farina, C., Andreoni, S., Blasi, E., Conte, M., Fazii, P., Lombardi, G., & Sanna, S. (2014) · Microbiologia medica · doi:10.4081/mm.2014.4888

Definitions and Epidemiology of Candida Species not Susceptible to Echinocandins

Pfaller, M. A., Diekema, D. J., Castanheira, M., & Jones, R. N. (2011) · Current Fungal Infection Reports · doi:10.1007/s12281-011-0053-y · Cited by 4